Mitsubishi Tanabe Pharma Canada, Inc

Pharmadrug Inc, based in Toronto, ON, specializes in the clinical development of natural-based medicines and the creation of bio-synthetic formulations for existing drugs. Their focus lies in addressing unmet needs in oncology and infectious diseases through the research, development, and commercialization of innovative treatments. The company is structured around two core divisions: Biotechnology and Synthetic Formulation. The Biotechnology division is dedicated to harnessing the potential of natural compounds, while the Synthetic Formulation division focuses on developing advanced formulations of established medications, particularly in relation to evolving drug policies. Pharmadrug Inc's commitment to advancing healthcare is evident through their emphasis on pioneering approaches to medical treatments and their dedication to improving patient outcomes in critical therapeutic areas. Generated from the website content

Neural Therapeutics Inc. is an ethnobotanical drug discovery and development company dedicated to researching and developing products utilizing psychoactive plants, notably the San Pedro cactus (Echinopsis pachanoi), which contains mescaline. The company emphasizes the importance of indigenous knowledge in the effective use of whole plant extracts, aiming to honor traditional practices while advancing modern pharmaceutical and nutraceutical applications. With a focus on sustainable practices, Neural Therapeutics follows a research and development roadmap that seeks to create zero waste by fully utilizing the plant's capabilities. Comprised of an experienced leadership team with expertise in environmental science, pharmacology, and corporate finance, the company is well-positioned to explore innovative solutions in the natural products industry. Generated from the website

Psyence Group Inc. is a life science biotechnology company based in Toronto, Ontario, focused on developing innovative, safe, and effective psychedelic and nature-centered solutions for mental health, particularly in the context of palliative care. The company specializes in natural psilocybin products and medicinal formulations aimed at treating anxiety, depression, and associated ailments within clinical environments. As one of the first federally licensed and ISO 22000 certified facilities for psilocybin cultivation and production, Psyence Group operates under the NASDAQ-listed entity Psyence Biomedical Ltd. The company's team comprises experts in neurology and pharmaceutical product commercialization, alongside a global executive team experienced in capital markets and sustainable growth. Generated from the website